Literature DB >> 15734297

In vivo in vitro correlations for a poorly soluble drug, danazol, using the flow-through dissolution method with biorelevant dissolution media.

Vibeke Hougaard Sunesen1, Betty Lomstein Pedersen, Henning Gjelstrup Kristensen, Anette Müllertz.   

Abstract

The purpose of the study was to design dissolution tests that were able to distinguish between the behaviour of danazol under fasted and fed conditions, by using biorelevant media. In vitro dissolution of 100mg danazol capsules was performed using the flow-through dissolution method. Flow rates were 8, 16 or 32 ml/min, corresponding to total volumes dissolution medium of 960, 1920 and 3840 ml, respectively. The media used contained bile salt and phospholipid levels relevant for either fasted or fed conditions in vivo. Crude and inexpensive bile components, Porcine Bile Extract and soybean phospholipids, were used as the bile source. The effect of adding different concentrations and molar ratios of monoglycerides and fatty acids to the fed state media was investigated. In vivo release profiles under fasted and fed conditions were obtained from a previous study by deconvolution [Sunesen, V.H., Vedelsdal, R., Kristensen, H.G., Christrup, L., Müllertz, A. 2005. Effect of liquid volume and food intake on the absolute bioavailability of danazol, a poorly soluble drug, Eur. J. Pharm. Sci. 24, 297-303]. In the fasted state, the physiologically most relevant correlation with in vivo results was achieved with a medium containing 6.3 mM bile salts and 1.25 mM phospholipids (8 ml/min). A medium containing 18.8 mM bile salts, 3.75 mM phospholipids, 4.0 mM monoglycerides and 30 mM fatty acids (8 ml/min) gave the closest correlation with fed state in vivo results. By using the flow-through dissolution method it was possible to obtain correlations with in vivo release of danazol under fasted and fed conditions. Both hydrodynamics and medium composition were important for the dissolution of danazol. In the fed state an IVIVC could only be obtained by including monoglycerides and fatty acids in the medium.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15734297     DOI: 10.1016/j.ejps.2004.11.007

Source DB:  PubMed          Journal:  Eur J Pharm Sci        ISSN: 0928-0987            Impact factor:   4.384


  21 in total

1.  An automated process for building reliable and optimal in vitro/in vivo correlation models based on Monte Carlo simulations.

Authors:  Steven C Sutton; Mingxiu Hu
Journal:  AAPS J       Date:  2006-05-05       Impact factor: 4.009

2.  Increasing the proportional content of surfactant (Cremophor EL) relative to lipid in self-emulsifying lipid-based formulations of danazol reduces oral bioavailability in beagle dogs.

Authors:  Jean F Cuiné; William N Charman; Colin W Pouton; Glenn A Edwards; Christopher J H Porter
Journal:  Pharm Res       Date:  2007-02-15       Impact factor: 4.200

3.  Dissolution media simulating conditions in the proximal human gastrointestinal tract: an update.

Authors:  Ekarat Jantratid; Niels Janssen; Christos Reppas; Jennifer B Dressman
Journal:  Pharm Res       Date:  2008-04-11       Impact factor: 4.200

4.  Population in vitro-in vivo correlation model for pramipexole slow-release oral formulations.

Authors:  Elena Soto; Sebastian Haertter; Michael Koenen-Bergmann; Alexander Staab; Iñaki F Trocóniz
Journal:  Pharm Res       Date:  2009-12-29       Impact factor: 4.200

5.  Hydrodynamic and species transfer simulations in the USP 4 dissolution apparatus: considerations for dissolution in a low velocity pulsing flow.

Authors:  Deirdre M D'Arcy; Bo Liu; Geoff Bradley; Anne Marie Healy; Owen I Corrigan
Journal:  Pharm Res       Date:  2009-12-10       Impact factor: 4.200

6.  Comparison of dissolution profiles for sustained release resinates of BCS class I drugs using USP apparatus 2 and 4: a technical note.

Authors:  Namita B Prabhu; Ajit S Marathe; SatishKumar Jain; Pirthi Pal Singh; Kiran Sawant; Leena Rao; Purnima D Amin
Journal:  AAPS PharmSciTech       Date:  2008-06-18       Impact factor: 3.246

7.  Dynamic dissolution testing to establish in vitro/in vivo correlations for montelukast sodium, a poorly soluble drug.

Authors:  Arthur Okumu; Marie DiMaso; Raimar Löbenberg
Journal:  Pharm Res       Date:  2008-06-17       Impact factor: 4.200

8.  Multivariate data analysis of factors affecting the in vitro dissolution rate and the apparent solubility for a model basic drug substance in aqueous media.

Authors:  Anita Maria Persson; Curt Pettersson; Josefin Rosén
Journal:  Pharm Res       Date:  2010-03-27       Impact factor: 4.200

9.  Evolution of Choice of Solubility and Dissolution Media After Two Decades of Biopharmaceutical Classification System.

Authors:  Nadia Bou-Chacra; Katherine Jasmine Curo Melo; Ivan Andrés Cordova Morales; Erika S Stippler; Filippos Kesisoglou; Mehran Yazdanian; Raimar Löbenberg
Journal:  AAPS J       Date:  2017-05-17       Impact factor: 4.009

10.  Preparation and in vitro/in vivo evaluation of microparticle formulations containing meloxicam.

Authors:  Hakan Eroglu; Nihan Burul-Bozkurt; Serdar Uma; Levent Oner
Journal:  AAPS PharmSciTech       Date:  2011-11-19       Impact factor: 3.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.